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Abstract Deep venous thrombosis (DVT) is a serious
complication of various medical conditions including acute
stroke. Our aim was to identify the occurrence of early
stroke-related DVT, risk factors for its development and the
inﬂuence on outcome. The study involved consecutive
patients admitted to our center due to acute ischaemic (n =
278) or haemorrhagic (n = 12) stroke during a 16-month
period. We collected data on their pre-stroke health status,
neurological deﬁcit on admission and baseline serum CRP
and ﬁbrinogen level. Ultrasonographic imaging was per-
formed at the 3rd (IQR: 2–4) and 9th (IQR: 8–9) day after
stroke. Patients thrombosis occurring between the ﬁrst and
second examination comprised the newly developed early
stroke-related DVT group. We found DVT in 8.0% (24/299)
of patients at initial evaluation. Newly developed DVT was
present in 3.0% (9/299) of patients, and was predominantly
distal (7 of 9 cases). It was associated with elevated serum
CRPlevel(OR8.75;95%CI:1.61–47.6),whichwasveriﬁed
in a model adjusted for stroke severity and pre-stroke
dependency (3–5 pts. in mRS). In a multivariate model,
newly developed DVT signiﬁcantly increased the risk of
3-month mortality (OR 12.4; 95%CI: 1.72–89.4), without
affecting the combined risk of dependency and death (OR
2.57; 95%CI: 0.39–17.0). Early stroke-related DVT is an
infrequent complication. However, it may be an indepen-
dent risk factor for 3-monthmortality. Increased serum CRP
level combined with normal ﬁbrinogen level seems pre-
dictive for development of DVT. It may be reasonable to
provide those patients with additional DVT prophylaxis.
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Introduction
Deep vein thrombosis (DVT), including pulmonary
embolism (PE) as a sequel, is a serious complication of
various medical conditions including stroke. It is consid-
ered to develop mostly within 2 weeks post-stroke [1]. The
incidence in immobilized post-stroke patients ranges from
10 to 75%, depending on the diagnostic method and time of
evaluation [1–5]. According to the literature, the major risk
factors of post-stroke DVT are older age [6], atrial ﬁbril-
lation [7] and limb paresis [8].
Most studies addressing the issue of DVT and stroke
tend to focus on patients with lower limb paresis and search
for in-hospital DVT. The initial ultrasound examination is
usually performed after 7 days from stroke onset, and the
second one 2–5 weeks after stroke. Such an approach is
sufﬁcient to evaluate the incidence of DVT in those
patients. However, it does not allow to distinguish between
early stroke-related and late onset DVT, nor with DVT
probably present before. We assume this difference is of
particular importance, as the late onset DTV is mainly
associated with prolonged immobility, and the early onset
DVT may be more likely a direct consequence of the
ischaemic cerebrovascular event.
The aim of our study was to establish the occurrence of
early stroke-related DVT, risk factors for its development
and the inﬂuence on 3-month outcome.
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We recruited consecutive patients admitted to our depart-
ment due to acute stroke from December 2007 to May
2009, excluding the period from May to August 2008. The
diagnosis of stroke was based on clinical symptoms and
brain CT imaging.
Neurological deﬁcit on admission was measured with
the National Institutes of Health Stroke Scale (NIHSS).
Stroke severity was categorized as mild (NIHSS B7 pts.),
moderate (NIHSS 8–14 pts.) or severe (NIHSS [14 pts.).
Pre-stroke disability was measured with Modiﬁed Rankin
Scale (mRS). Information about pre-existing comorbidities
and oral anticoagulation or heparins was obtained from
patients medical records, patients themselves or their
proxies if necessary. We also collected data on serum
routine CRP level (immuno-turbidimetric method, Syn-
chron CX 7, Beckman Coulter) and serum ﬁbrinogen level
(Claus method, Synchron CX 7, Beckman Coulter) mea-
sured within 24 h from hospital admission.
The follow-up examination was provided 3 months after
stroke onset by a physician blinded to the patient’s DVT
status during a routine outpatient visit or by phone.
Primary outcome measures were overall mortality, and
combined death or dependency (3–6 pts. in mRS).
Ultrasonographic examination
Patients were examined for both proximal (popliteal,
femoral and common femoral vein) and distal (peroneal
and tibial veins) DVT. The ﬁrst ultrasonographic exami-
nation was performed within the ﬁrst 7 days and then 8–10
after stroke onset by a trained physician (JB) blinded to
patients’ baseline health status in order to identify patients
in whom DVT occurred early in the course of stroke. We
used Vivid 7 Dimension (GE, USA) with the 7–10 Hz
linear probe. The diagnosis of DVT was based either on
presence of a non-compressible segment (compression
ultrasound test—CUS) or the ﬂow impairment on color
Doppler imaging. This method is recognized as sufﬁciently
sensitive and speciﬁc, especially in proximal DVT detec-
tion [9].
DVT prevention
None of DVT prevention methods were used routinely.
Patients at high risk of developing DVT received low
molecular weight heparins (LMWH) at physican’s discre-
tion. Patients diagnosed with DVT were treated with full
dose LMWH.
Ethics committee approval
The study protocol was approved by the local Ethics
committee. As DVT screening with Doppler USG is non-
invasive and safe, we did not collect patients written con-
sent for the examination. The follow-up outpatient visit
after 3 months is a routine element of post stroke care in
our department.
Statistical methods
Categorical variables were presented as ratio with number
of valid observations, and continuous variables as median
with interquartile range (IQR). Proportions were calculated
with exclusion of unknown values from the denominator.
In basic comparative statistics we applied chi square test or
two sided exact Fisher’s test, and Mann–Whitney U test,
for categorical and continuous variables, respectively.
Multivariate logistic regression was adjusted for all
independentoutcomepredictors.Toavoidvariableselection
caused by spurious correlations, only variables showing a
relationship to the outcome (deﬁned P\0.10 in the uni-
variate model) were included as potential predictors. We
identify theﬁnalmultivariate modelforeach majoroutcome
usingabackwardstepwiseapproachwiththeP\0.05ofthe
likelihood ratio test for exclusion of excess factors.
We considered P value\0.05 statistically signiﬁcant.
Analyses were conducted in STATISTICA 8.0 (StatSoft,
Inc. 2008).
Results
During the recruitment period of 16 months a total of 425
acute stroke patients were admitted to our stroke unit. We
excluded 102 patients who were not able to undergo initial
USG evaluation due to early transfer to another hospital,
death or unstable general condition not allowing to transfer
the patients to the USG laboratory. We also excluded 24
patients who were lost from the follow-up USG due to
reasons similar as mentioned above.
Patients excluded from the study had more severe neu-
rological deﬁcit at baseline, and more frequently decreased
level of consciousness. 39 (31%) of them died during the
hospital stay at a median of 2 days (IQR: 2–4). A detailed
description of both groups is presented in Table 1.
The ﬁnal analysis involved 299 Caucasian patients with
acute ischaemic (92.8%) and haemorrhagic (7.2%) stroke.
The initial and follow-up USG examinations were per-
formed at the 3rd (IQR: 2–4) and 9th (IQR: 8–9) day after
stroke, respectively. The median gap between examina-
tions was 6 (IQR: 4–7) days.
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123We found DVT in 24 (8.0%) patients at initial and in 32
(10.7%) patients at follow-up examination. In one case, the
clot resolved before the second examination. Therefore,
newly developed DVT was present in nine (3.0%) patients,
and was predominantly distal (7 cases).
Patients with newly developed DVT despite a trend for
younger age (median 68 vs. 75; P = 0.429) tended to have
higher ratio of pre-existing diabetes (33.3 vs. 17.7%;
P = 0.213) and congestive heart failure (44.4 vs. 24.2%;
P = 0.233). There was also a trend for higher stroke
severity (median NIHSS score 8 vs. 5; P = 0.090),
including more frequently decreased consciousness (33.3
vs. 13.8%; P = 0.125). Patients with DVT had signiﬁ-
cantly higher ratio of elevated serum CRP level (77.8 vs.
32.6%; P = 0.008) with a strong inverse trend for elevated
serum ﬁbrinogen level (44.4 vs. 73.6%; P = 0.067).
Detailed characteristic of the study population is presented
in Table 2.
In a multivariate model, development of early stroke-
related DVT was associated with elevated serum CRP
concentration and not-increased serum ﬁbrinogen concen-
tration. There was also a positive trend for pre-stroke
diabetes. Pre-stroke dependency and stroke severity did not
show signiﬁcant association, nor trend for increased risk of
DVT. Detailed OR for early stroke-related DVT are pre-
sented in Table 3.
Patients with early stroke-related DVT had signiﬁcantly
higher 3-month mortality (42.9 vs. 9.2%, P = 0.03), and
slightly more frequently developed death or dependency
(57.1 vs. 41.1%, P = 0.45). In multivariate logistic
regression early stroke-related DVT was associated with
increased risk of death at 3 months (OR 12.4; 95%CI:
1.72–89.4), after adjusting for the independent predictors
(i.e. older age, use of oral anticoagulants, stroke severity
and elevated CRP concentration) (Table 4).
Early stroke-related DVT did not signiﬁcantly inﬂuence
3-month death or dependency. After adjusting for the
independent predictors (i.e. stroke severity and pre-stroke
disability level), the OR in early stroke-related DVT was
2.57 (95%CI: 0.39–17.0). It also did not inﬂuence the
outcome in survivors. After adjusting for the independent
predictors (i.e. age, stroke severity and pre-stroke disability
level), the OR for dependency in survivors (mRS 2–5 pts.)
in early stroke-related DVT patients was 1.83 (95%CI:
0.17–20.1) (Table 4).
Discussion
Our ﬁndings show, that the frequency of DVT in acute
stroke patients reaches 10.7%. However, in 8% of cases is
may have developed before the stroke, while only in 3%
Table 1 Comparison of the
study group and patients not
included in the study
Not included Included P
N Observed (%) N Observed (%)
Age (median, IQR) 126 72 (62–81) 299 75 (64–82) 0.162
Female sex 126 62 (49.2%) 299 159 (53.2%) 0.454
Arterial hypertension 126 89 (70.6%) 288 214 (74.3%) 0.438
Congestive heart failure 123 32 (26.0%) 290 72 (24.8%) 0.799
Atrial ﬁbrillation 123 30 (24.4%) 290 61 (21.0%) 0.452
Diabetes 124 16 (12.9%) 297 54 (18.2%) 0.185
Smoking status
Current smokers 123 28 (22.8%) 298 74 (24.8%) 0.652
Past smokers 122 55 (45.1%) 296 140 (47.3%) 0.680
Oral anticoagulants 125 14 (11.2%) 296 21 (7.1%) 0.163
Pre-stroke disability
mRS 0–1 pt. 126 85 (67.5%) 299 218 (72.9%) 0.257
mRS 0–2 pts. 126 95 (75.4%) 299 246 (82.3%) 0.104
Stroke severity (median, IQR%) 126 8 (3–20) 299 5 (2–9) \0.001
NIHSS B7 pts. 126 59 (46.8%) 299 205 (68.6%) \0.001
NIHSS 8–14 pts. 126 20 (15.9%) 299 52 (17.4%) 0.703
NIHSS[14 pts. 126 47 (37.3%) 299 42 (14.0%) \0.001
Decreased consciousness
Not present 126 78 (61.9%) 299 256 (85.6%) \0.001
1 pt. in NIHSS 126 24 (19.0%) 299 30 (10.0%) 0.011
C2 pts. in NIHSS 126 24 (19.0%) 299 13 (4.3%) \0.001
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123between the 3rd and 9th day after stroke. According to
previous studies, the incidence of DVT within the ﬁrst
14 days post-stroke ranges from 10 to 75% of patients,
depending on the applied methodology [1–5].
In a recent large trial by Dennis et al. [10] a total of 2518
acute stroke patients randomized to thigh-length graduated
compression stockings for DVT prevention (n = 1256) or
routine care (n = 1262) were evaluated with a compression
ultrasound test at 7–10 days after stroke and if possible at
25–30 days after enrollment. In the initial examination, the
ratio of combined symptomatic and asymptomatic DVT
was 10.0% in the study group and 10.5% in the control
group, which is fully consistent with our results. In another
USG-based study, De Silva et al. assessed the incidence of
DVT in 105 acute ischaemic stroke Asian patients. At the
ﬁrst evaluation performed 7–10 days after stroke they
found DVT in 30% of patients. On follow-up evaluation,
performed 25–30 days after stroke, DVT was detected in
45% of patients. Those results may suggest that Asian
population is more prone to develop DVT, when compared
to Caucasians [11]. The protocol used in our study differed
from previous ones and included two USG examina-
tions performed in the acute phase of stroke within a gap of
a few days. This allowed us to differentiate patients in
whom DVT was most likely a direct consequence of
the acute stroke, and not chronic immobility or pre-stroke
thrombosis.
In our study, newly developed early stroke-related DVT
was predominantly distal (7 of 9 cases), which stays in
concordance with other studies [5, 11–14]. We decided to
search for distal DVT as it also poses an indirect but sig-
niﬁcant threat, as the thrombi propagates above the knee in
Table 2 Baseline
characteristics of the study
population and 3-month
outcomes
Newly developed DVT
group
Old DVT or non-DVT
group
P
N Observed (%) N Observed (%)
Age (median, IQR) 9 68.0 (63–79) 290 75 (65–82) 0.429
Female sex 9 5 (55.6%) 290 154 (53.1%) 1.000
Arterial hypertension 9 7 (77.8%) 279 207 (74.2%) 1.000
Congestive heart failure 9 4 (44.4%) 281 68 (24.2%) 0.233
Atrial ﬁbrillation 9 2 (22.2%) 281 59 (21.0%) 1.000
Diabetes 9 3 (33.3%) 288 51 (17.7%) 0.213
Smoking status
Current smokers 9 2 (22.2%) 289 72 (24.9%) 1.000
Past smokers 9 4 (44.4%) 287 136 (47.4%) 1.000
Oral anticoagulants 9 0 (0%) 287 21 (7.3%) 1.000
Pre-stroke disability
mRS 0–1 pt. 9 6 (66.7%) 290 222 (74.1%) 0.707
mRS 0–2 pts. 9 8 (88.9%) 290 238 (82.1%) 1.000
Ischaemic stroke 9 9 (100.0%) 290 269 (92.8%) 1.000
Stroke severity [median, IQR] 9 8 (4–20.5) 290 5 (2–9) 0.090
NIHSS B7 pts. 9 4 (44.4%) 290 201 (69.3%) 0.146
NIHSS 8–14 pts. 9 3 (33.3%) 290 49 (16.9%) 0.193
NIHSS[14 pts. 9 2 (22.2%) 290 40 (138%) 0.368
Decreased consciousness
Not present 9 6 (66.7%) 290 250 (86.2%) 0.125
1 pt. in NIHSS 9 2 (22.2%) 290 28 (9.7%) 0.225
C2 pts. in NIHSS 9 1 (11.1%) 290 12 (4.1%) 0.333
Inﬂammatory markers
CRP[10 mg/dl 9 7 (77.8%) 276 90 (32.6%) 0.008
Fibrinogen[4 mg/dl 9 4 (44.4%) 276 203 (73.6%) 0.067
Fibrinogen [median, IQR] 9 3.8 (3.4–5.8) 276 4.7 (4.0–5.8) 0.230
Stroke outcome at 3 months
Mortality 7 3 (42.9%) 275 27 (9.8%) 0.028
Death or dependency (mRS 3–6%) 7 4 (57.1%) 275 113 (41.1%) 0.454
Dependency in survivors (mRS 3–5%) 4 1 (25.0%) 248 86 (34.7%) 1.000
Early stroke-related deep venous thrombosis 99
123even up to 20% of cases [15, 16]. Therefore, the risk of
proximal extension and possibility of developing PE as a
sequel should not be neglected [17].
We assume that the cases of newly developed DVT may
be signiﬁcantly different from those diagnosed in other
studies using only one USG examination during the ﬁrst
2 weeks post stroke. In our study population, patients
presenting with DVT at the ﬁrst USG examination were
less independent before stroke and did not show any
increase in 3-month mortality [18]. Therefore, we cannot
be certain when the clot formation was triggered. It is
possible, that in many cases DVT was already present
before stroke onset.
The results of other studies provide evidence that the
development of DVT is associated with elevation of sys-
temic inﬂammatory markers [19, 20], which is partially
consistent with our ﬁndings.
However, the issue of cause-and-results relationship of
increased inﬂammatory markers and DVT is still a matter
of debate. Besides, the number of published studies
on acute stroke patients is very limited. In this aspect,
our study provides a new perspective. It allows us to
Table 3 Unadjusted and adjusted odds ratio for early stroke-related DVT
Univariate model Multivariate model*
OR 95%CI P OR 95%CI P
Age (for each additional 10 years) 0.91 (0.70–1.19) 0.507 0.64 (0.33–1.23) 0.176
Female sex 1.10 (0.29–4.22) 0.885 0.81 (0.20–3.37) 0.775
Hypertension 1.22 (0.25–6.04) 0.809 1.44 (0.27–7.61) 0.665
Congestive heart failure 2.51 (0.65–9.65) 0.180 1.71 (0.41–7.05) 0.458
Atrial ﬁbrillation 1.08 (0.22–5.34) 0.929 0.65 (0.12–3.48) 0.609
Diabetes 2.32 (0.56–9.65) 0.244 4.16 (0.84–20.6) 0.079
Smoking status
Current smoker 0.86 (0.17–4.37) 0.854 1.59 (0.28–8.89) 0.599
Previous smoker 0.89 (0.23–3.39) 0.862 0.97 (0.24–3.93) 0.969
Pre–stroke disability 1.05 (0.65–1.72) 0.834 0.97 (0.58–1.62) 0.923
mRS 0–1 pt. 0.74 (0.18–3.03) 0.670 0.95 (0.21–4.23) 0.947
mRS 0–2 pts. 1.75 (0.21–14.4) 0.602 0.44 (0.05–3.90) 0.460
Stroke severity
Each additional 4 pts. NIHSS 1.30 (0.96–1.75) 0.083 1.21 (0.86–1.69) 0.271
NIHSS[7 pts. 2.82 (0.74–10.8) 0.129 2.11 (0.50–8.96) 0.307
NIHSS[14 pts. 1.79 (0.35–8.96) 0.479 1.34 (0.25–7.30) 0.732
Decreased consciousness
C1 pt. in NIHSS 3.13 (0.75–13.1) 0.117 2.09 (0.46–9.54) 0.337
C2 pts. in NIHSS 2.90 (0.33–25.3) 0.334 1.90 (0.19–19.0) 0.583
Inﬂammatory markers
CRP[10 mg/l 7.23 (1.46–35.8) 0.015 10.1 (1.93–52.9) 0.006
Fibrinogen[4 mg/dl 0.29 (0.07–1.11) 0.069 0.18 (0.04–0.74) 0.017
* Adjusted for elevated blood CRP level ([10 mg/dl) and ﬁbrinogen level ([4 mg/dl)
Table 4 Adjusted odds ratio for 3-month mortality and unfavorable outcome (mRS 2–6)
Death at 3 months* Death or dependency
a
OR 95%CI P OR 95%CI P
Newly developed DVT 12.4 (1.72–89.4) 0.012 2.57 (0.39–17.0) 0.324
Age (for each additional 10 years) 2.05 (1.17–3.59) 0.011 1.55 (1.14–2.10) 0.005
Oral anticoagulants 5.58 (1.11–28.1) 0.036
Pre-stroke nondisability (mRS 0–1) 0.25 (0.12–0.50) \0.001
Stroke severity (for each 4 NIHSS) 1.78 (1.36–2.31) \0.001 2.79 (2.08–3.74) \0.001
CRP[10 mg/l 2.94 (1.08–7.96) 0.034
* Model adjusted for all presented variables;
a Model adjusted for all presented excluding newly developed DVT
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123distinguish patients developing stroke-related DVT in a
very narrow time window after baseline evaluation, as the
ultrasound examinations were performed with the median
interval of 4 days. Such design gives information about the
level of inﬂammatory markers directly preceding the clot
formation, and has not been applied before. In other studies
the gap between USG evaluation usually ranges from 2 to
4 weeks [10, 11].
The increase of CRP level in patients with DVT, that we
observed in our study, is fully consistent with published
literature. However other studies, have not concentrated on
stroke patients [19, 21, 22].
Surprisingly, our ﬁndings show that early stroke related
DVT is inversely associated with elevated ﬁbrinogen level.
Unfortunately, available studies supporting the positive
association between DVT and serum ﬁbrinogen were
conducted on small groups of patients, did not have such a
narrow time window and did not address directly the acute
stroke [23–27]. Therefore, it is difﬁcult to make direct
comparisons. We may speculate, that observed in our study
inverse association between the elevated ﬁbrinogen level
and the development of DVT is a result of ﬁbrinogen
depletion due to active clot formation. However, this
assumption is based on a small group of stroke patients,
and gives a good rationale for further investigations.
In a study by Wang et al. the mean levels of plasma CRP
and ﬁbrinogen were signiﬁcantly higher in 59 DVT patients
compared to 26 healthy controls, i.e. 2.67 ± 0.91 versus
0.14 ± 0.08 mg/dl. Similar observation was made for
ﬁbrinogen (4.73 ± 1.36 vs. 2.79 ± 0.66 g/l, respectively).
The authors suggest that interaction between inﬂammation
and coagulation promote the development of DVT and may
be involved in DVT pathogenesis [23]. Unfortunately, this
was a small study and only the abstract is available in
English. Therefore, its methodology stays unclear.
Ogata et al. [28] attempted to detect DVT in 56 acute
haemorrhagic stroke patients within 72 h from the onset of
symptoms and after 2 weeks using ultrasonography. They
did not ﬁnd any signiﬁcant correlation between ﬁbrinogen
level and risk of DVT. However, trials not concentrating
directly on stroke patients suggest that elevated ﬁbrinogen
level is associated with even a 4-fold increase in the risk of
developing DVT [24–27].
According to our ﬁndings, pre-stroke disability level and
stroke severity were independent predictors of achieving
unfavorable outcome during the follow-up, which stays in
concordance with other studies [29–32].
It is generally agreed that proper DVT prophylaxis
improves stroke outcome, although there is no evidence
supporting this thesis [33]. In our study early stroke-related
DVT was an independent risk factor for death at 3 months
with a slight trend for unfavorable outcome in survivors.
De Silva et al. [11] reported that the presence of DVT
25–30 days after stroke was associated with higher ratio of
poor outcome (deﬁned as mRS 4–6) after 6 months (50 vs.
26%; P = 0.024). In patients diagnosed with DVT during
7–10 days after stroke this association was not statistically
signiﬁcant (52 vs. 32%; P = 0.074). Therefore, patients
with acute stroke should be carefully screened for DVT
risk factors at admission. Throughout the hospitalization
they should also be at least clinically monitored for the
development of DVT. It applies to all patients regardless
of stroke severity, especially if serum CRP levels are
elevated.
None of our patients was diagnosed with PE, however,
the majority of deaths occurred after discharge from the
hospital.Wemay speculate, thatearlystroke-related DVT is
a clinical marker of other discrete conditions that increase
the risk of death. It is also possible that those patients are
more likely to have serious clinical course of thrombosis
with higher risk of PE despite applied treatment.
Our study has certain limitations. Although ultrasound is
highly sensitive and speciﬁc in detection of proximal DVT
in symptomatic patients, it’s sensitivity for distal DVT
detection is much lower than proximal (62.1 vs. 93.9%)
[34]. The sample size of early stroke-related DVT was too
small (9 cases) to draw strong conclusions. Our cohort is
skewed towards relatively stable patients with mild-to-
severe strokes not requiring early transfer to other specialist
units. Only two basic inﬂammation markers were tested in
this study. We also did not perform routine autopsy in
patients who died during the study period, therefore we
cannot exclude that some deaths were due to PE.
In conclusion, our study shows that DVT which is
deﬁnitely associated with acute stroke occurs in 3% of
patients and signiﬁcantly affects 3-month mortality. Ele-
vated serum CRP level and not-increased ﬁbrinogen serum
level are independently associated with increased risk of
DVT. Therefore, it may be reasonable to provide this group
of patients with additional care and proper DVT prophy-
laxis in order to minimize the risk of thrombo-embolic
complications.
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